| Literature DB >> 28333615 |
Alessandra Natale1, John Stelling2, Marcello Meledandri3, Louisa A Messenger4, Fortunato D'Ancona5,6.
Abstract
Resistant pathogens infections cause in healthcare settings, higher patient mortality, longer hospitalisation times and higher costs for treatments. Strengthening and coordinating local, national and international surveillance systems is the cornerstone for the control of antimicrobial resistance (AMR). In this study, the WHONET-SaTScan software was applied in a hospital in Italy to identify potential outbreaks of AMR. Data from San Filippo Neri Hospital in Rome between 2012 and 2014 were extracted from the national surveillance system for antimicrobial resistance (AR-ISS) and analysed using the simulated prospective analysis for real-time cluster detection included in the WHONET-SaTScan software. Results were compared with the hospital infection prevention and control system. The WHONET-SaTScan identified 71 statistically significant clusters, some involving pathogens carrying multiple resistance phenotypes. Of these 71, three were also detected by the hospital system, while a further 15, detected by WHONET-SaTScan only, were considered of relevant importance and worth further investigation by the hospital infection control team. In this study, the WHONET-SaTScan system was applied for the first time to the surveillance of AMR in Italy as a tool to strengthen this surveillance to allow more timely intervention strategies both at local and national level, using data regularly collected by the Italian national surveillance system. This article is copyright of The Authors, 2017.Entities:
Keywords: Italian national surveillance; WHONET SaTScan; antimicrobial resistance clusters; automated surveillance; infection control; outbreaks
Mesh:
Year: 2017 PMID: 28333615 PMCID: PMC5356424 DOI: 10.2807/1560-7917.ES.2017.22.11.30484
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X
Characteristics of isolates from San Filippo Neri Hospital extracted from MICRONET, Italy, January 2012–May 2014 (n = 7,994 isolates)
| Isolates characteristics | Number of isolates | Percentage |
|---|---|---|
| Year | ||
| 2012 | 3,419 | 42.7 |
| 2013 | 3,327 | 41.7 |
| 2014a | 1,248 | 15.6 |
| Sex | ||
| Female | 4,340 | 54.3 |
| Male | 3,616 | 45.2 |
| Missing information | 38 | 0.5 |
| Specimen type | ||
| Urine | 2,972 | 37.2 |
| Pus | 1,598 | 20.0 |
| Blood | 893 | 11.2 |
| Tracheal aspirate | 578 | 7.2 |
| Vaginal swab | 367 | 4.6 |
| Cervical test | 254 | 3.2 |
| Sputum | 238 | 3.0 |
| Aspirateb | 203 | 2.5 |
| Nasal swab | 168 | 2.1 |
| Throat swab | 161 | 2.0 |
| Others | 562 | 7.0 |
| Organism group | ||
| Gram-negative | 4,483 | 56.0 |
| Gram-positive | 2,984 | 37.3 |
| Mycoplasma | 272 | 3.4 |
| Anaerobe | 183 | 2.3 |
| Fungi | 57 | 0.7 |
|
| 15 | 0.2 |
| Department of origin | ||
| Outpatient | 2,720 | 34.0 |
| Medicine | 1,970 | 24.6 |
| Surgery | 1,767 | 22.1 |
| Intensive/intermediate care unit | 1,108 | 13.8 |
| Obstetric/gynaecology | 160 | 2.0 |
| Neonatology | 121 | 1.5 |
| Haematology/oncology | 85 | 1.1 |
| Emergency | 49 | 0.6 |
| Psychiatry | 14 | 0.2 |
a Data are from the first 5 months of 2014 only.
b Aspirates other than tracheal aspirates.
Summary characteristics of clusters generated by WHONET-SatScan in San Filippo Neri Hospital, Italy, 2012–2014 (n = 71 clusters)
| Cluster characteristics | Number | Percentagea |
|---|---|---|
| Total number | 71 | 100 |
| Average number of clusters per month | 4.5 | NA |
| Year | ||
| 2012 | 17 | 24.0 |
| 2013 | 42 | 59.1 |
| 2014 | 12 | 16.9 |
| Pathogen type | ||
|
| 18 | 25.4 |
|
| 13 | 18.3 |
|
| 7 | 9.9 |
|
| 5 | 7.0 |
|
| 4 | 5.6 |
|
| 2 | 2.8 |
| Other | 22 | 31.0 |
| Type of alerts | ||
| Ward and resistance profile | 24 | 33.8 |
| Resistance profile | 21 | 29.5 |
| Serviceb and resistance profile | 16 | 22.5 |
| Serviceb | 4 | 5.7 |
| Pathogen type | 4 | 5.7 |
| Ward | 2 | 2.8 |
| Mean number of signals per cluster (95% CI) | 1.73 | (1.53–1.93) |
| Number of cases | ||
| Total | 700 | 100 |
| Median per cluster (range) | 4 | (2–143) |
| Cluster length in days | ||
| 1 | 10 | 14.1 |
| 2–5 | 17 | 24.0 |
| 6–10 | 10 | 14.1 |
| 11–50 | 21 | 29.5 |
| > 50 | 13 | 18.3 |
CI: confidence interval; NA: not applicable.
a Unless otherwise specified in the row heading.
b A group of wards with communal care is defined as ‘service’.
Comparison between Acinetobacter baumannii and Klebsiella pneumoniae alerts detected by San Filippo Neri’s CPCIO and WHONET-SaTScan systems, Italy, 2012–2014
| Year | Organism | Detected by the CPCIO | Detected by WHONET-SaTScan | Agreement between the two systems | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number of alerts | Date of activation | Ward | Number of casesa | Number of alerts | Start date | Ward | Number of cases | |||
| 2012 |
| 1 | 14 Aug | ICU | ≥ 3 | 0 | NA | NA | NA | 50 |
|
| 1 | 11 Sep | ICU | ≥ 3 | 1 | 22 Sep | OUT | 2 | ||
| 2013 |
| 1 | 27 Jun | ICU | ≥ 3 | 1 | 20 May | NSW | 13 | 100 |
|
| 1 | 11 Oct | ICU | ≥ 3 | 1 | 6 May | ICU | 6 | ||
|
| 1 | 27 Nov | ICU | ≥ 3 | 1 | 3 Aug | ICU | 3 | ||
| 2014 |
| 1 | Aprb | ICU | ND | 0 | NA | NA | NA | NA |
CPCIO: Commissione Prevenzione e Controllo delle Infezioni Ospedaliere (hospital infections control team); ICU: intensive care unit; KPC: Klebsiella pneumoniae carbapenem-resistant; MDR: multidrug resistant; NA: not applicable; ND: no data; NSW: no specific ward; OUT: outpatient ward; XDR: extensive drug-resistant.
a The number of cases detected by the CPCIO is at least three to trigger the activation of control response as per outbreak definition (see text for details).
b The exact date of activation was not available at the time of this study and only an unofficial report from 2014 was available.
FigureDistribution of Acinetobacter baumannii XDR cases and cluster alerts, San Filippo Neri Hospital, Italy, January 2013–May 2014
Cluster alerts detected by WHONET-SaTScan in San Filippo Neri Hospital considered relevant by the hospital’s infection control system (CPCIO) and critical characteristics of the alerts for the evaluation, Italy, 2012–2014 (n = 18 alerts)
| Organisma | Type of alert | Alert characteristicsb | Dates of outbreak (start–end) | Recurrence interval | Observed cases | Observed/ expected case ratio | Time span in days | CPCIO evaluation |
|---|---|---|---|---|---|---|---|---|
| 2012 | ||||||||
|
| Ward/res | Gen med | 5 Sep–22 Sep | 1/1.14 | 18 | 2.51 | 19 | Pat/res |
|
| Ward/res | Vascular surgery | 12 Oct–22 Oct | 1/1.25 | 4 | 7.02 | 11 | Pat/res |
|
| Ward/res | Vascular surgery | 22 Oct–25 Oct | 1/19.85 | 2 | 6.06 | 4 | Ward |
|
| Res | SXT | 13 Nov–15 Nov | 1/22.40 | 2 | 5.56 | 3 | Pat/res |
| 2013 | ||||||||
|
| Ward/res | Neuro-rehab | 20 Apr–20 Apr | 1/1.52 | 2 | 153.85 | 1 | Ward |
|
| Res | CTX, CAZ, CIP, GEN, TZP, SXT | 6 May–6 Jun | 1/23.69 | 6 | 46.15 | 32 | Pat/res |
|
| Serv/res | Neonatology | 10 Jun–12 Jun | 1/1.30 | 2 | 21.05 | 3 | Pat/res/serv |
|
| Res | LVX, OXA, PEN | 26 Apr–22 Jun | 1/1.44 | 10 | 4.13 | 58 | Pat/res |
|
| Ward/res | ICU | 15 Jun–1 Jul | 1/1.44 | 3 | 23.08 | 17 | Pat/res/ward |
|
| Serv/res | ICU | 19 May–15 Jul | 1/2.11 | 3 | 4.76 | 58 | Pat/res/serv |
|
| Res | CTX, CAZ, CIP, GEN, IPM, MEM, SXT | 20 May–1 Aug | 1/2.00 | 13 | 3.56 | 74 | Pat/res |
|
| Serv/res | ICU | 3 Aug–7 Aug | 1/2.78 | 3 | 38.96 | 5 | Pat/res/serv |
|
| Serv | Interm care unit | 26 Aug–27 Sep | 1/4.13 | 4 | 9.52 | 33 | Serv |
|
| Serv | Interm care unit | 5 Oct–18 Oct | 1/1.25 | 3 | 15.79 | 14 | Serv |
|
| Ward/res | Ortho-Trauma | 2 Dec–2 Dec | 1/2.11 | 2 | 142.86 | 1 | Pat/res/ward |
|
| Serv/res | Gen Med | 24 Dec–3 Jan 2014 | 1/1.37 | 2 | 9.09 | 11 | Pat/res/serv |
| 2014 | ||||||||
|
| Serv/res | Surgery | 31 Mar–31 Mar | 1/2.49 | 2 | 105.26 | 1 | Pat/res/serv |
|
| Ward/res | ICU | 14 Apr–28 May | 1/3.26 | 2 | 4.35 | 45 | Pat/res/ward |
Gen med: general medicine; ICU: intensive care unit; interm care unit: intermediate care unit; neuro-rehab: neuro-rehabilitation; ortho-trauma: orthopaedic trauma; pat: pathogen type; res: resistance; serv: service.
a The organisms are abbreviated as follows: A. baumannii: Acinetobacter baumannii; E. aerogenes: Enterobacter aerogenes; E. coli: Escherichia coli; E. faecium: Enterococcus faecium; K. pneumoniae: Klebsiella pneumoniae; P. aeruginosa: Pseudomonas aeruginosa; S. aureus: Staphylococcus aureus; S. maltophila: Stenotrophomonas maltophila; S. marcescens: Serratia marcescens.
b Antibiotics listed in this column are abbreviated as follows: AMK: amikacin; AMP: ampicillin; CAZ: ceftazidime; CIP: ciprofloxacin; CTX: cefotaxime; ERY: erythromycin; GEN: gentamicin; IPM: imipenem; LVX: levofloxacin; MEM: meropenem; MFX: moxifloxacin; OXA: oxacillin; PEN: penicillin; SXT: trimethoprim/sulfamethoxazole; TZP: tazobactam; VAN: vancomycin.